Prophylaxis of Venous Thrombo-Embolism in Cancer Patients... | NCT00303407

Studies
Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

NCT00303407

Sponsor

University Hospital, Geneva

Status

Terminated

Last Update Posted

Mar 16, 2006Estimated

Enrollment

Not provided

Phase

Not provided

Conditions

Cancer
Venous Thromboembolism

Interventions

nadroparin

Countries

Switzerland

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Dec 2005

Overall Recruitment Status or Expanded Access Status

Terminated

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 2001

Primary Completion Date

Not provided

Completion Date

Jul 2002

First Submitted Date

Mar 15, 2006

First Submission Date that Met QC Criteria

Mar 15, 2006

First Posted Date

Mar 16, 2006Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 15, 2006

Last Update Posted Date

Mar 16, 2006Estimated

Description Module

Brief Summary

To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

Not provided

Name	Type	Description	Arm Group Labels	Other Names
nadroparin	Drug

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Cancer patients in palliative care
Patients fully informed about their condition
Signed informed consent
No exclusion criteria

Exclusion Criteria:

Absence of advanced cancer
Cancer previously cured
Venous thromboembolism diagnosed within 6 months prior to inclusion
Absence of discerning capacity
Active anti-thrombotic treatment with heparins or coumarines
Thrombocytopenia <50G/l
PTT >45sec
TP<35%
Active bleeding
Renal failure <20ml/min
Past history of heparin-induced thrombocytopenia

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

0 Years

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Catherine Weber, MD	Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Center of Continuous Care, chemin de la Savonnière		Collonge-Bellerive (Geneva)	Canton of Geneva	1245	Switzerland

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
9198144	Background	Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost. 1997 Jul;78(1):141-4.

ID	Term
D013923	Thromboembolism
D016769	Embolism and Thrombosis
D014652	Vascular Diseases
D002318	Cardiovascular Diseases

ID	Term
D006495	Heparin, Low-Molecular-Weight
D006493	Heparin
D006025	Glycosaminoglycans
D011134	Polysaccharides

ID	Term
D009369	Neoplasms
D054556	Venous Thromboembolism